Bronchogen 10mg (10 vials/kit): Short-Chain Bioregulatory Peptide for Respiratory & Bronchial Epithelial Research

Bronchogen is a synthetic short-chain bioregulatory peptide belonging to the Khavinson peptide family, rationally designed to target the bronchopulmonary system. Composed of a targeted amino acid sequence ($\text{Ala-Asp-Glu-Leu}$ / $\text{L-Alanyl-L-Aspartyl-L-Glutamyl-L-Leucine}$), Bronchogen interacts directly with chromatin in bronchial epithelial cells and alveolar tissue to restore protein synthesis and cellular metabolism. Sourcing Bronchogen 10mg (10 vials/kit) provides pulmonology researchers, cell biologists, and respiratory physiology laboratories with an advanced analytical reagent engineered to evaluate bronchial tissue repair, mucociliary clearance dynamics, and inflammatory cytokine attenuation in vitro and in vivo.

In pulmonary pathology and respiratory cell culture models, environmental toxins, oxidative stress, and chronic inflammatory signals disrupt epithelial cell turn-over, impairing ciliary beat frequency and surfactant homeostasis. As a short-chain signal peptide, Bronchogen penetrates nuclear membranes to bind specific histone-DNA sites, inducing chromatin unfolding and upregulating gene expression associated with structural epithelial proteins and endogenous antioxidant enzymes:

Simultaneously, Bronchogen modulates nuclear factor-$\kappa\text{B}$ ($\text{NF-}\kappa\text{B}$) signaling, suppressing the hypersecretion of pro-inflammatory cytokines ($\text{TNF-}\alpha$, $\text{IL-6}$, $\text{IL-8}$) and matrix metalloproteinases in inflamed lung tissue explants.

Maintaining exact batch stoichiometry and structural stability is critical for quantitative gene expression profiling and respiratory cell bioassays. The Bronchogen 10mg (10 vials/kit) product configuration supplies a total yield of 100mg active research peptide (10mg per vial) distributed across ten individual USP Type I borosilicate glass vials. Freeze-dried under sterile vacuum conditions, each vial contains a uniform, highly stable lyophilized cake. This multi-vial kit structure enables researchers to reconstitute single working units as needed, keeping remaining stock preserved under deep-freeze conditions to prevent hydrolytic degradation.

Bronchial Bioregulation, Mucociliary Support, and Technical Profile

The primary scientific value of Bronchogen 10mg (10 vials/kit) stems from its epigenetic transcriptional activation, cytoprotective properties, and targeted pulmonary signaling dynamics:

• Epigenetic Transcriptional Modulation: Interacts directly with nucleosome histones in bronchial cells to reactivate suppressed protein synthesis pathways.

• Epithelial Barrier Restoration: Accelerates repair and regeneration of ciliated bronchial epithelial cells and type II alveolar pneumocytes in damaged tissue models.

• Inflammatory Cytokine Attenuation: Suppresses $\text{NF-}\kappa\text{B}$-driven transcription, reducing production of pro-inflammatory cytokines ($\text{IL-6}$, $\text{IL-8}$, $\text{TNF-}\alpha$) during pulmonary challenge assays.

• Mucociliary Clearance & Surfactant Balance: Helps maintain normal surfactant expression and mucus viscosity parameters in respiratory cell cultures.

• Ultra-High Chemical Purity ($\ge$99.0%): Manufactured via automated Solid-Phase Peptide Synthesis ($\text{SPPS}$) and purified using preparative High-Performance Liquid Chromatography ($\text{HPLC}$) to ensure absolute chemical purity.

Reconstitution Guidelines, Laboratory Storage Standards, and Quality Protocols

Achieving reproducible, publication-grade results when working with Bronchogen 10mg (10 vials/kit) requires strict adherence to standardized laboratory preparation and climate-controlled storage protocols.

Perform all reconstitution procedures inside a certified Class II Biosafety Cabinet:

1. Temperature Balancing: Allow the frozen Bronchogen vial to adjust to ambient room temperature prior to solvent introduction to eliminate moisture condensation inside the glass container.

2. Septum Sanitization: Remove the protective plastic flip-cap and thoroughly wipe the synthetic rubber stopper with a fresh 70% isopropyl alcohol pad. Allow the surface to dry completely.

3. Slow Diluent Addition: Using a sterile syringe equipped with a fine-gauge needle, draw the required volume of Bacteriostatic Water (0.9% benzyl alcohol), Sterile Normal Saline (0.9% NaCl), or Phosphate-Buffered Saline (PBS). Direct the liquid stream against the inner glass wall so it trickles slowly over the lyophilized cake.

4. Gentle Hydration: Allow the diluent to fully hydrate the powder cake for 2 minutes. Gently roll the vial between your palms or swirl in smooth circular motions until clear. Never vortex or shake violently, as high-shear agitation can disrupt peptide secondary structures and induce protein foaming.

5. Micro-Aliquot Strategy: For multi-week testing protocols, divide reconstituted liquid into sterile, single-use microcentrifuge tubes under aseptic conditions to prevent atmospheric oxidation and eliminate repeated freeze-thaw cycles.

Batch Quality Documentation & Traceability: Every production lot of Bronchogen 10mg (10 vials/kit) undergoes third-party analytical testing. High-Performance Liquid Chromatography (HPLC) chromatograms confirm component purity exceeding 99.0%, while Electrospray Ionization Mass Spectrometry (ESI-MS) confirms precise theoretical molecular mass. Each shipment includes a batch-specific Certificate of Analysis (COA) documenting chemical purity, residual solvent analysis, heavy metal screens, and bacterial endotoxin levels (<0.05 EU/mg) to satisfy institutional compliance requirements.

Strict Regulatory & Research Compliance Statement: Bronchogen 10mg (10 vials/kit) is produced, packaged, and distributed exclusively for in vitro laboratory research, academic experimentation, chemical synthesis, and preclinical research. Bronchogen 10mg (10 vials/kit) is strictly not intended, formulated, or approved for human or animal consumption, therapeutic medical treatment, clinical diagnostic work, or cosmetic applications. All handling must be conducted by certified research personnel operating within equipped laboratory facilities in compliance with OSHA workplace safety regulations and institutional biosafety protocols.